ImmunoCellular Therapeutics, Ltd. announced a private placement of convertible promissory notes for a gross proceeds of $5,000,000 in funding on August 26, 2022. The minimum investment accepted from any outside investor is $25,000. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 USD | +14.16% | +6.11% | -9.48% |
1st Jan change | Capi. | |
---|---|---|
-9.48% | 20.84M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- EOM Pharmaceuticals Holdings, Inc. announced a financing transaction